Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

The 2022 Tandem Meetings | Making stem cell transplantation more affordable for low and middle-income countries

Guillermo José Ruiz-Argüelles • 23 Apr 2022
The 2022 Tandem Meetings
General

In low and middle-income countries, cost is a major barrier to access to autologous and allogeneic stem cell transplantation (SCT). In this video, Guillermo José Ruiz-Argüelles, MD, FRCP, Universidad Popular Autónoma del Estado de Puebla, Puebla, Mexico, outlines strategies to reduce the costs of these procedures, including using non-frozen cells and more affordable drugs, as well as performing SCT on an outpatient basis. This interview took place at the Transplantation & Cellular Therapy (TCT) Meetings of ASTCT™ and CIBMTR® 2022 in Salt Lake City, Utah.

More from Guillermo José Ruiz-Argüelles

Recommendations for transplantation in countries with limited resources
2:49
Recommendations for transplantation in countries with limited resources
Guillermo José Ruiz-Argüelles • 8 Oct 2022
High-dose melphalan as a preparative regimen for autoHSCT in HL and NHL
2:22
High-dose melphalan as a preparative regimen for autoHSCT in HL and NHL
Guillermo José Ruiz-Argüelles • 23 Apr 2022
autoHSCT as the best predictor for long-term survival in multiple myeloma
2:18
autoHSCT as the best predictor for long-term survival in multiple myeloma
Guillermo José Ruiz-Argüelles • 23 Apr 2022

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals